Enterprise Innovation Road | Hengsheng Medicine: Core Technology

Just a "的" sound, the nurse completed the patient's blood sugar test with the handheld blood glucose meter. There was no previous handwritten data and no complicated data record books. The doctor could view patient information, blood sugar detection data and past test records in the mobile terminal. Instant monitoring of changes in the condition and adjusting treatment plan.

The realization of this scene is a national specialized new "little giant" enterprise Hengsheng Medical Technology Co., Ltd. Since the establishment of the enterprise for more than 20 years, it has grown from a blood glucose detection product agent dealer to a deep -cultivating professional field.

Right now, in Hengsheng Medical Production Workshop, various production lines are stepping up medical equipment such as blood glucose detector, biosensor testing, and in vitro detection biochemical agents to ensure the supply of blood glucose and blood pressure in medical service institutions.

On September 9, in the production workshop of Hengsheng Medical Technology Co., Ltd., technical workers are checking the automated production line of blood sugar test strips running at high speed. Drawing

"With the continuous improvement of market demand, corporate revenue has increased for many years. Nowadays, in addition to the continuous improvement of production capacity, the company is still constantly improving the product structure and industrial chain." Wang Hui, deputy general manager of the company's administrative manager, believes that the achievements of these achievements cannot be separated from the same achievement. The long -term high R & D investment in enterprises has effectively forged the "long board" of the core technology of the product.

Hengsheng Medicine was established in September 2010. It was originally an agent dealer engaged in blood sugar testing products. In 2012, enterprises were built into the production R & D center in Urumqi to begin independent research and development of products. In 2013, the enterprise applied for the patent of the blood glucose instrument, and gradually expanded from a single blood glucose testing product to blood pressure products, medical software, insulin pumps, biochemical reagents, chronic disease management and other endocrine fields through independent innovation and investment mergers and acquisitions.

Since the promotion of independent brands, Hengsheng Medicine has opened up the clinical market in the field of blood sugar testing in Xinjiang and Northwest China. In 2014, it began to move from the Northwest Market to the national market. Essence

On the road of innovation and development, Hengsheng Medicine has continued to make progress, established an enterprise technology center in the autonomous region, and established an independent intellectual property system. The blood glucose information management platform and biosensor test film were obtained and affirmed. Kung Fu is worthy of care, from SMEs of "Specialty New" to growing into a specialized new "Little Giant" enterprise. Currently, Hengsheng Medicine has 10 wholly -owned subsidiaries in the country, 4 of which produce and develop companies, 6 Home sales companies have established a good reputation in the medical equipment circle.

At the National Industrial APP and Information Consumption Competition in 2021, the "Slow Disease Informatization Management Platform" by Hengsheng Medical R & D won an information consumption application innovation award. Up to now, the "Slow Disease Information Management Platform" has been put into use in more than 500 hospitals across the country, and has achieved the sharing of patients with chronic disease testing for patients, facilitating internal hospital consultations, patients with discharged doctors, and can also be analyzed by slow disease data trend charts. Including medication analysis, health consultation, etc.

Not only the blood glucose testing record, but also the test records such as blood pressure and blood oxygen on the chronic disease information management platform. Insulin, oral hypoglycemic and antihypertensive drug management, equipment quality control management, you can also view health information related to chronic diseases Essence

Today, Hengsheng Medicine actively expands market sales channels and provides convenient services. The online platform has established the "Doctor Doctor's Official Flagship Store". The product uses blood glucose detection systems, dynamic blood glucose meters, insulin pumps and other medical equipment, supporting medical software and biochemical reagents Mainly, prepare to expand the global market simultaneously. "The company is developing the technical research and development of POCT (instant inspection) equipment such as diabetes such as diabetes to make up for domestic shortcomings, and gradually improve the upstream and downstream industrial chain and expand the international market." Wang Hui said.

Source: Tianshan.com -Xinjiang Daily Original

- END -